The purpose of this FOA is to encourage new and innovative mechanistic studies of pathogens that impact placental function and fetal well-being, with the long-term goal of informing the development of interventions against these pathogens and reducing the burden of infection-related pregnancy loss and infant morbidity and mortality.
Letter of Intent Due: September 13, 2011
Application Due: October 13 , 2011
To support basic to translational research focused on development of new therapeutic strategies for neurotropic intoxication or infection caused by select biodefense pathogens.
Letter of Intent Due:September 23, 2011
Application Due: October 24, 2011
To participate in a cooperative study group focused on prevention of human autoimmune disease. For the purpose of this FOA, “prevention of autoimmune disease” is defined as halting the development of an autoimmune disease prior to clinical onset by means other than global immunosuppression. The study group has as its foundation a set of cooperative agreements coordinated by a Steering Committee, and also draws upon an Infrastructure and Opportunities Fund to support a range of innovative, collaborative, and pilot/feasibility projects.
Letter of Intent Due:October 7, 2011
Application Due: November 8, 2011
To encourage applications from institutions/organizations proposing innovative, high risk, high impact research to identify novel vaccine concepts and targets that will aid in the design and development of an effective immunogen that may provide long-term protection from acquisition of HIV. The emphasis of this FOA is early discovery research that incorporates new ideas leading to the development of new conventional or outside-the-box approaches for vaccines that may have significant impact on the design of novel immunogens or immunization strategies for an effective HIV vaccine. The program is open to established and new investigators and does not require research expertise in HIV prevention as a prerequisite for submitting an application.
Letter of Intent Due:December 6, 2011
Application Due: January 6, 2011
To solicit grant applications with the goal of stimulating innovation in the discovery and development of therapeutics that target host-encoded functions required for infection, replication, spread and/or pathogenesis by one or more NIAID Category A, B, or C priority pathogens.
Letter of Intent Due:October 31, 2011
Application Due: November 30, 2011
CO-Pilot Translational Research Grant Program
The CO-Pilot Grant Program of the CCTSI is a series of one-year awards meant to encourage cross-disciplinary and collaborative research in clinical and translational medicine. Translational research is intentionally broadly and includes any basic, pre-clinical or clinical research with promise to improve human health. Therefore, basic research at the cellular and molecular level, pre-clinical research in animal models, clinical research in humans, and outcomes or health services research are all included.
Letter of Intent Due:August 26, 2011
Application Due: September 26, 2011